Earnings Feed
Start Free
10x Genomics, Inc.·4

Jan 7, 4:52 PM ET

Saxonov Serge 4

4 · 10x Genomics, Inc. · Filed Jan 7, 2026

Insider Transaction Report

Form 4
Period: 2026-01-05
10x Genomics, Inc.TXG
Saxonov Serge
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Class A Common Stock

    2026-01-05$1.20/sh+50,000$60,000→ 1,071,556 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-05−17,463→ 0 total
    Exercise: $1.20Exp: 2027-10-18→ Class A Common Stock (17,463 underlying)
  • Exercise/Conversion

    Stock Option (right to buy)

    2026-01-05−32,537→ 173,600 total
    Exercise: $1.20Exp: 2027-10-18→ Class A Common Stock (32,537 underlying)
Holdings

  • Class A Common Stock

    (indirect: See footnote)
    27

  • Class A Common Stock

    (indirect: See footnote)
    213,250

  • Class A Common Stock

    (indirect: See footnote)
    58,000
Footnotes (4)
  • [F1]The shares are held by the Andromeda Trust, for which the Reporting Person serves as trustee.
  • [F2]The shares are held by the Y/S Descendants' Trust, for which the Reporting Person serves as trustee.
  • [F3]The shares are held by the Y/S Pot Trust, for which the Reporting Person serves as trustee.
  • [F4]All of the shares subject to the option are fully vested and exercisable as of the date hereof.

Documents

1 file
  • 4
    form4.xmlPrimary